Search

Author/Creator Gauler, Thomas C

1. Dynamic contrast-enhanced MRI parameters as biomarkers for the effect of vatalanib in patients with non-small-cell lung cancer. (April 2014)

Authors:
Nensa, Felix; Stattaus, Jörg; Morgan, Bruno; Horsfield, Mark A; Soria, Jean-Charles; Besse, Benjamin; Gounant, Valerie; Khalil, Antoine; Seng, Katja; Fischer, Berthold; Krissel, Heiko; Laurent, Dirk; Christoph, Daniel; Eberhardt, Wilfried EE; Gauler, Thomas C
Journal:
Future oncology
Issue:
Volume 10:Number 5(2014)
Page Start:
823
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the 'Arbeitsgemeinschaft Internistische Onkologie' (AIO-PK0104). Issue 5 (7th July 2012)

Authors:
Heinemann, Volker; Vehling-Kaiser, Ursula; Waldschmidt, Dirk; Kettner, Erika; Märten, Angela; Winkelmann, Cornelia; Klein, Stefan; Kojouharoff, Georgi; Gauler, Thomas C; von Weikersthal, Ludwig Fischer; Clemens, Michael R; Geissler, Michael; Greten, Tim F; Hegewisch-Becker, Susanna; Rubanov, Oleg...
Journal:
Gut
Issue:
Volume 62:Issue 5(2013)
Page Start:
751
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search